JP2005529129A - 胃腸管障害におけるgababレセプターポジティブモジュレーターの使用 - Google Patents
胃腸管障害におけるgababレセプターポジティブモジュレーターの使用 Download PDFInfo
- Publication number
- JP2005529129A JP2005529129A JP2003587367A JP2003587367A JP2005529129A JP 2005529129 A JP2005529129 A JP 2005529129A JP 2003587367 A JP2003587367 A JP 2003587367A JP 2003587367 A JP2003587367 A JP 2003587367A JP 2005529129 A JP2005529129 A JP 2005529129A
- Authority
- JP
- Japan
- Prior art keywords
- gaba
- visceral
- gerd
- treatment
- ibs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (4)
- GERD、逆流、IBS、消化不良、術後愁訴および内臓不快感/内臓痛に伴う病状の処置におけるGABABレセプターのポジティブアロステリックモジュレーター(GABABレセプターモジュレーター)として作用する化合物の使用。
- GERD、逆流、IBS、消化不良、術後愁訴および内臓不快感/内臓痛に伴う病状の処置用医薬組成物の製造のためのGABABレセプターモジュレーターの使用。
- GERD、逆流、IBS、消化不良、術後愁訴および内臓不快感/内臓痛に伴う病状の処置において使用するための、少なくとも1つの医薬担体または希釈剤とともにGABABレセプターモジュレーターを含んでなる医薬組成物。
- GERD、逆流、IBS、消化不良、術後愁訴および内臓不快感/内臓痛に伴う病状の処置方法であって、かかる処置を必要としている対象において、かかる対象にGABABレセプターモジュレーターの治療上有効量を投与することを含んでなる方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0209481.1A GB0209481D0 (en) | 2002-04-24 | 2002-04-24 | Organic compounds |
PCT/EP2003/004217 WO2003090731A1 (en) | 2002-04-24 | 2003-04-23 | Use of gabab receptor positive modulators in gastro-instestinal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005529129A true JP2005529129A (ja) | 2005-09-29 |
Family
ID=9935503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003587367A Pending JP2005529129A (ja) | 2002-04-24 | 2003-04-23 | 胃腸管障害におけるgababレセプターポジティブモジュレーターの使用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050245613A1 (ja) |
EP (2) | EP1642573A1 (ja) |
JP (1) | JP2005529129A (ja) |
AU (1) | AU2003229716A1 (ja) |
GB (1) | GB0209481D0 (ja) |
WO (1) | WO2003090731A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070224284A1 (en) | 2004-03-12 | 2007-09-27 | John Devane | Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof |
EP1725239B1 (en) | 2004-03-02 | 2007-07-18 | F.Hoffmann-La Roche Ag | 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy |
SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
ES2348246T3 (es) | 2004-11-01 | 2010-12-01 | F. Hoffmann-La Roche Ag | Quinolinas como activadores alostéricos de receptores gaba-b. |
ES2324231T3 (es) | 2004-12-17 | 2009-08-03 | F. Hoffmann-La Roche Ag | Derivados de tieno-piridina como intensificadores alostericos de gaba-b. |
CN101189208A (zh) | 2005-06-02 | 2008-05-28 | 弗·哈夫曼-拉罗切有限公司 | 作为gaba-b增强剂的3-甲磺酰基喹啉 |
CA2632016A1 (en) | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Imidazole derivatives for the treatment of gastrointestinal disorders |
EP1968947A1 (en) | 2005-12-23 | 2008-09-17 | AstraZeneca AB | Gaba-b receptor modulators |
PL2124884T3 (pl) | 2006-12-22 | 2020-01-31 | Ironwood Pharmaceuticals, Inc. | Metody i kompozycje do leczenia zaburzeń przełyku |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
TWI263496B (en) * | 1999-12-10 | 2006-10-11 | Novartis Ag | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
WO2001090141A2 (en) * | 2000-05-25 | 2001-11-29 | Merck Frosst Canada & Co. | Gb1c isoform and nucleotides |
-
2002
- 2002-04-24 GB GBGB0209481.1A patent/GB0209481D0/en not_active Ceased
-
2003
- 2003-04-23 JP JP2003587367A patent/JP2005529129A/ja active Pending
- 2003-04-23 EP EP05022671A patent/EP1642573A1/en not_active Withdrawn
- 2003-04-23 EP EP03722530A patent/EP1501488A1/en not_active Withdrawn
- 2003-04-23 US US10/512,014 patent/US20050245613A1/en not_active Abandoned
- 2003-04-23 WO PCT/EP2003/004217 patent/WO2003090731A1/en not_active Application Discontinuation
- 2003-04-23 AU AU2003229716A patent/AU2003229716A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1501488A1 (en) | 2005-02-02 |
AU2003229716A1 (en) | 2003-11-10 |
EP1642573A1 (en) | 2006-04-05 |
GB0209481D0 (en) | 2002-06-05 |
WO2003090731A1 (en) | 2003-11-06 |
US20050245613A1 (en) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6931019B2 (ja) | 多発性硬化症を処置するためのs1p受容体モジュレーター | |
JP4098832B2 (ja) | 逆流抑制剤 | |
KR100765579B1 (ko) | 제약학적 조합물 및 이의 위장 질병의 치료를 위한 용도 | |
JP2003523324A5 (ja) | ||
JP2021503480A (ja) | トラジピタントを用いた胃腸疾患の治療方法 | |
US20120009183A1 (en) | Method for treatment of pancreatitis | |
BR112020016500A2 (pt) | Agente preventivo ou terapêutico e composição farmacêutica para doença inflamatória ou doença óssea | |
JP5274838B2 (ja) | 化合物 | |
JP2005529129A (ja) | 胃腸管障害におけるgababレセプターポジティブモジュレーターの使用 | |
JP4034849B2 (ja) | 慢性腺維形成性肝疾患、急性肝疾患およびそれに関わる合併症の治療および予防のための非ペプチドブラジキニン拮抗剤の使用 | |
JP2008528615A (ja) | プロトンポンプ阻害剤により誘発され得る遅延した胃内容排出の処置のための5−ht4アゴニストの使用 | |
EP0323162B1 (en) | New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters | |
JP6051431B2 (ja) | 消化管運動促進剤として機能する5−ht4受容体作動物質 | |
US9132108B2 (en) | Pharmaceutical composition for ameliorating and/or preventing leptin resistance, and use thereof | |
TWI296522B (en) | Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients | |
Viazis et al. | Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: A placebo controlled study using esophageal pH-impedance monitoring | |
CA3085706A1 (en) | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | |
JP4880477B2 (ja) | 胃粘膜疾患の治療のための医薬組成物 | |
TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
JPWO2004026296A1 (ja) | 抗ストレス性疾患組成物 | |
EP3409271A1 (en) | Means to facilitate food intake and food retention | |
US20100204286A1 (en) | Method for reducing gastrointestinal adverse effects of cytotoxic agents | |
EP4188351A1 (en) | N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl) ethynyl]-benzohydrazide for treatment of alzheimer's disease | |
JP2023501114A (ja) | 哺乳動物の過労の予防及び/又は治療に使用するための4-[5-[(rac)-1-[5-(3-クロロフェニル)-3-イソキサゾリル]エトキシ]-4-メチル-4h-1,2,4-トリアゾール-3-イル]ピリジン | |
JP2016169205A (ja) | 汗分泌促進剤及び該汗分泌促進剤を含有するドライスキンの予防薬又は治療薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080304 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080523 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080530 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080723 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080730 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081104 |